21 results
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
interstitial lung disease ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... SSc #pulmonary #indications
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... HCQ treatment would ... Even with macular disease ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology #Table
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Summary of meta-analysis ... with ‘treatment ... summarised in Tables ... Personality #Disorder #Medications ... Effectiveness #Table
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
intracranial pressure • Dialysis ... Inhibitors of Na+K+2Cl ... Tolvaptan) • Treatment ... #Pharmacology #Medications ... #Table
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
: • Most CNS opportunistic ... • CNS opportunistic ... Antimicrobial treatment ... Demyelinating disease ... /Edema • EBV analysis
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Treatment of underlying ... disease 2. ... urine output: 200 ml ... per day until stable ... Dialysis for severe
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... suspension 4–6 mL ... for effective treatment ... #management #opportunistic
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
100 Dosing: 250 mcg ... tablet once daily ... increase to 500 mcg ... recommendations for the treatment ... the use of this medication
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
dermatitis, a disease ... recommendations, treatments ... inflammatory skin disease ... This disease imposes ... #management #medications
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Shock, Autoimmune disease ... Anterior circulation: MCA ... Electrolyte abnormality, Medication ... epilepticus Treatment ... underlying cause • Treatment